These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 985563
41. Inhibitors of monoamine oxidase. V. Effect of substitution on the transport of tetrahydro-beta-carboline analogs to mouse brain. Ho BT, Fritchie GE, Kralik PM, Tansey LW, Walker KE, McIsaac WM. J Pharm Sci; 1969 Nov; 58(11):1423-5. PubMed ID: 5349767 [No Abstract] [Full Text] [Related]
42. Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine. Fuller RW. Biochem Pharmacol; 1968 Oct; 17(10):2097-106. PubMed ID: 5696879 [No Abstract] [Full Text] [Related]
46. Dietary inhibitors of monoamine oxidase A. Dixon Clarke SE, Ramsay RR. J Neural Transm (Vienna); 2011 Jul; 118(7):1031-41. PubMed ID: 21190052 [Abstract] [Full Text] [Related]
47. Biochemistry and pharmacology of tryptamines and beta-carbolines. A minireview. McKenna DJ, Towers GH. J Psychoactive Drugs; 1984 Jul; 16(4):347-58. PubMed ID: 6394730 [No Abstract] [Full Text] [Related]
48. The metabolism of indolealkylamines by type A and B monoamine oxidase of brain. Neff NH, Yang HY, Goridis C, Bialek D. Adv Biochem Psychopharmacol; 1974 Jul; 11(0):51-8. PubMed ID: 4845688 [No Abstract] [Full Text] [Related]
50. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets. Airaksinen MM, Svensk H, Tuomisto J, Komulainen H. Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):308-13. PubMed ID: 7368950 [Abstract] [Full Text] [Related]
51. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat. Egashira T, Ekstedt B, Kinemuchi H, Wiberg A, Oreland L. Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813 [Abstract] [Full Text] [Related]
52. Influence of chlorpromazine on brain serotonin turnover and body temperature in isolated aggressive mice. Goldberg ME, Dubnick B, Hefner M, Salama AI. Neuropharmacology; 1973 Mar; 12(3):249-60. PubMed ID: 4735416 [No Abstract] [Full Text] [Related]
56. Some pharmacological and biochemical properties of gamma-morpholino-butyrophenone (NSD 2023), a new monoamine oxidase inhibitor. Squires RF, Lassen JB. Biochem Pharmacol; 1968 Mar; 17(3):369-84. PubMed ID: 5661650 [No Abstract] [Full Text] [Related]
57. 6-Methoxy-1,2,3,4-tetrahydro-beta-carboline produces a retention deficit for one-trial passive avoidance in mice. Buckholtz. Behav Biol; 1975 May; 14(01):95-101. PubMed ID: 1137537 [No Abstract] [Full Text] [Related]
58. The heterogeneity of monoamine oxidase in distinct populations of rat brain mitochondria. Owen F, Bourne R. Biochem Pharmacol; 1977 Feb 15; 26(4):289-92. PubMed ID: 849318 [No Abstract] [Full Text] [Related]
59. Inhibition of monoamine oxidase by furazolidone in germfree rats. Yeung TC, Goldman P. Biochem Pharmacol; 1981 Sep 01; 30(17):2496-7. PubMed ID: 21043255 [No Abstract] [Full Text] [Related]
60. The kinetics of monoamine oxidase inhibition by three 2-indolylmethylamine derivatives. Cruces MA, Elorriaga C, Fernández-Alvarez E. Biochem Pharmacol; 1990 Aug 01; 40(3):535-43. PubMed ID: 2383286 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]